DMC Biotechnologies
PrivateLast Round
Series B
Jan 31, 2022
Total Funding Raised
$54.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
DMC Biotechnologies is a biotechnology company that develops bio-based specialty chemicals and ingredients using a proprietary precision fermentation technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DMC Biotechnologies Comparables
Compare DMC Biotechnologies with similar companies based on industry and business-model similarity.
DMC Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 31, 2022 | ||||
| Series A | Dec 16, 2019 | ||||
| Grant | Nov 18, 2019 | ||||
| Seed | Oct 8, 2018 | ||||
| Seed | Jan 9, 2018 |
Key People
Founding team and executive leadership
DMC Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capricorn Partners | Series A, Series B, Seed |
| Conti Ventures | Series B |
| Breakthrough Energy Ventures | Series A, Series B, Seed |
| Sofinnova Partners | Series B, Series A |
| Boulder Ventures | Series A, Series B |
| Syensqo Ventures | Series B |
| Continental Grain Company | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 80% MoM.
- May 4, 2026
Preparing for commercial launch of myo-inositol and d-chiro-inositol ingredients.
DMC Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DMC Biotechnologies's valuation, stock price, and market status.
Is DMC a public or private company?
DMC is a private company.
What is the current stock price of DMC?
DMC is a private company with no public stock price. No recent secondary market data is available.
How much is DMC worth (valuation)?
Valuation information for DMC is not publicly available.
Can I buy DMC stock?
DMC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was DMC's last funding round?
DMC's most recent funding round was Series B on January 31, 2022.
Who are the main investors in DMC?
Key investors in DMC include Capricorn Partners, Sofinnova Partners.
Will DMC IPO soon?
No public IPO plans have been announced for DMC.
How can I track DMC secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DMC's secondary market activity and sign up for updates.